Carasent ASA
OSE:CARA

Watchlist Manager

Carasent ASA

OSE:CARA

Watchlist

Dividends

Price: 20.5 NOK 2.5% Market Closed

Market Cap: 1.5B NOK

Have any thoughts about
Carasent ASA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 20.5 NOK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

CARA Alert

Carasent ASA

20.5

+0.5 (+2.5%)

52 Week Range	10.1 20.5
Price Target

We'll email you a reminder when the closing price reaches NOK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Carasent ASA

What unique competitive advantages
does Carasent ASA hold over its rivals?

What risks and challenges
does Carasent ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Carasent ASA.

What unique competitive advantages
does Carasent ASA hold over its rivals?

What risks and challenges
does Carasent ASA face in the near future?

Summarize the latest earnings call
of Carasent ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Carasent ASA.

Provide P/S
for Carasent ASA.

Provide P/E
for Carasent ASA.

Provide P/OCF
for Carasent ASA.

Provide P/FCFE
for Carasent ASA.

Provide P/B
for Carasent ASA.

Provide EV/S
for Carasent ASA.

Provide EV/GP
for Carasent ASA.

Provide EV/EBITDA
for Carasent ASA.

Provide EV/EBIT
for Carasent ASA.

Provide EV/OCF
for Carasent ASA.

Provide EV/FCFF
for Carasent ASA.

Provide EV/IC
for Carasent ASA.

Show me price targets
for Carasent ASA made by professional analysts.

What are the Revenue projections
for Carasent ASA?

How accurate were the past Revenue estimates
for Carasent ASA?

What are the Net Income projections
for Carasent ASA?

How accurate were the past Net Income estimates
for Carasent ASA?

What are the EPS projections
for Carasent ASA?

How accurate were the past EPS estimates
for Carasent ASA?

What are the EBIT projections
for Carasent ASA?

How accurate were the past EBIT estimates
for Carasent ASA?

Compare the revenue forecasts
for Carasent ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Carasent ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Carasent ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Carasent ASA compared to its peers.

Compare the P/E ratios
of Carasent ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Carasent ASA with its peers.

Analyze the financial leverage
of Carasent ASA compared to its main competitors.

Show all profitability ratios
for Carasent ASA.

Provide ROE
for Carasent ASA.

Provide ROA
for Carasent ASA.

Provide ROIC
for Carasent ASA.

Provide ROCE
for Carasent ASA.

Provide Gross Margin
for Carasent ASA.

Provide Operating Margin
for Carasent ASA.

Provide Net Margin
for Carasent ASA.

Provide FCF Margin
for Carasent ASA.

Show all solvency ratios
for Carasent ASA.

Provide D/E Ratio
for Carasent ASA.

Provide D/A Ratio
for Carasent ASA.

Provide Interest Coverage Ratio
for Carasent ASA.

Provide Altman Z-Score Ratio
for Carasent ASA.

Provide Quick Ratio
for Carasent ASA.

Provide Current Ratio
for Carasent ASA.

Provide Cash Ratio
for Carasent ASA.

What is the historical Revenue growth
over the last 5 years for Carasent ASA?

What is the historical Net Income growth
over the last 5 years for Carasent ASA?

What is the current Free Cash Flow
of Carasent ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Carasent ASA.

EV/EBITDA
Enterprise Value to EBITDA

47.4

Current

35.5

Median

12.8

Industry

Higher than median

Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

47.4

Enterprise Value

1.1B NOK

EBITDA

24m NOK

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
NO	C	Carasent ASA OSE:CARA	1.5B NOK	47.4
US		Veeva Systems Inc NYSE:VEEV	35B USD	48.1
US	C	Cerner Corp LSE:0R00	31.3B USD	21.9
AU		Pro Medicus Ltd ASX:PME	23.2B AUD	195.6
US		Doximity Inc NYSE:DOCS	9B USD	38.6
JP		M3 Inc TSE:2413	967.6B JPY	12.3
US		Inspire Medical Systems Inc NYSE:INSP	5.7B USD	285.2
US	W	Waystar Holding Corp NASDAQ:WAY	5.4B USD	21.5
SE		Sectra AB STO:SECT B	53.1B SEK	-70.9
US	V	Vocera Communications Inc F:V00	2.4B EUR	239.2
CN		Winning Health Technology Group Co Ltd SZSE:300253	16.4B CNY	32.7

				EBITDA Growth
NO	C	Carasent ASA OSE:CARA	Average EV/EBITDA: 94.3 47.4	756%
US		Veeva Systems Inc NYSE:VEEV	48.1	187%
US	C	Cerner Corp LSE:0R00	21.9	N/A
AU		Pro Medicus Ltd ASX:PME	195.6	113%
US		Doximity Inc NYSE:DOCS	38.6	88%
JP		M3 Inc TSE:2413	12.3	24%
US		Inspire Medical Systems Inc NYSE:INSP	285.2	N/A
US	W	Waystar Holding Corp NASDAQ:WAY	21.5	N/A
SE		Sectra AB STO:SECT B	Negative Multiple: -70.9	N/A
US	V	Vocera Communications Inc F:V00	239.2	N/A
CN		Winning Health Technology Group Co Ltd SZSE:300253	32.7	143%

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

26.3

2-Years Forward

EV/EBITDA

12.9

3-Years Forward

EV/EBITDA

Carasent ASA
OSE:CARA

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Carasent ASA OSE:CARA

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Carasent ASA
OSE:CARA

EV/EBITDA
Enterprise Value to EBITDA